Clinical Trial Update: AZA Combined with R-GemOx for Elderly DLBCL Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates azacitidine plus rituximab-gemcitabine-oxaliplatin (R-GemOx) in elderly patients with diffuse large B-cell lymphoma. The study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• AZA (azacitidine)
• R-GemOx (rituximab, gemcitabine, oxaliplatin)

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING